Induction of leptin resistance through direct interaction of C-reactive protein with leptin

被引:234
作者
Chen, K
Li, FH
Li, J
Cai, HB
Strom, S
Bisello, A
Kelley, DE
Friedman-Einat, M
Skibinski, GA
McCrory, MA
Szalai, AJ
Zhao, AZ
机构
[1] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, Div Endocrinol & Bone Metab, Pittsburgh, PA 15261 USA
[4] Univ Pittsburgh, Obes & Nutr Res Ctr, Pittsburgh, PA 15261 USA
[5] Agr Res Org, Inst Anim Sci, Volcani Ctr, IL-50250 Bet Dagan, Israel
[6] Univ Alabama, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA
关键词
D O I
10.1038/nm1372
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanisms underlying leptin resistance are still being defined. We report here the presence in human blood of several serum leptin-interacting proteins (SLIPs), isolated by leptin-affinity chromatography and identified by mass spectrometry and immunochemical analysis. We confirmed that one of the major SLIPs is C-reactive protein (CRP). In vitro, human CRP directly inhibits the binding of leptin to its receptors and blocks its ability to signal in cultured cells. In vivo, infusion of human CRP into ob/ob mice blocked the effects of leptin upon satiety and weight reduction. In mice that express a transgene encoding human CRP, the actions of human leptin were completely blunted. We also found that physiological concentrations of leptin can stimulate expression of CRP in human primary hepatocytes. Recently, human CRP has been correlated with increased adiposity and plasma leptin. Thus, our results suggest a potential mechanism contributing to leptin resistance, by which circulating CRP binds to leptin and attenuates its physiological functions.
引用
收藏
页码:425 / 432
页数:8
相关论文
共 46 条
[1]   Leptin [J].
Ahima, RS ;
Flier, JS .
ANNUAL REVIEW OF PHYSIOLOGY, 2000, 62 :413-437
[2]   Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome [J].
Aronson, D ;
Bartha, P ;
Zinder, O ;
Kerner, A ;
Markiewicz, W ;
Avizohar, O ;
Brook, GJ ;
Levy, Y .
INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (05) :674-679
[3]   The role of SOCS-3 in leptin signaling and leptin resistance [J].
Bjorbæk, C ;
El-Haschimi, K ;
Frantz, JD ;
Flier, JS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (42) :30059-30065
[4]   ACUTE-PHASE RESPONSE OF HUMAN HEPATOCYTES - REGULATION OF ACUTE-PHASE PROTEIN-SYNTHESIS BY INTERLEUKIN-6 [J].
CASTELL, JV ;
GOMEZLECHON, MJ ;
DAVID, M ;
FABRA, R ;
TRULLENQUE, R ;
HEINRICH, PC .
HEPATOLOGY, 1990, 12 (05) :1179-1186
[5]   Recombinant methionyl human leptin administration to achieve high physiologic or pharmacologic leptin levels does not alter circulating inflammatory marker levels in humans with leptin sufficiency or excess [J].
Chan, JL ;
Bullen, J ;
Stoyneva, V ;
DePaoli, AM ;
Addy, C ;
Mantzoros, CS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03) :1618-1624
[6]  
DEBEER FC, 1982, IMMUNOLOGY, V45, P55
[7]   Leptin and the regulation of body weight in mammals [J].
Friedman, JM ;
Halaas, JL .
NATURE, 1998, 395 (6704) :763-770
[8]   Serum leptin activity in obese and lean patients [J].
Friedman-Einat, M ;
Camoin, L ;
Faltin, Z ;
Rosenblum, CI ;
Kaliouta, V ;
Eshdat, Y ;
Strosberg, AD .
REGULATORY PEPTIDES, 2003, 111 (1-3) :77-82
[9]  
Gura T, 1999, SCIENCE, V286, P881
[10]   A leptin dose-response study in obese (ob/ob) and lean (+/?) mice [J].
Harris, RBS ;
Zhou, J ;
Redmann, SM ;
Smagin, GN ;
Smith, SR ;
Rodgers, E ;
Zachwieja, JJ .
ENDOCRINOLOGY, 1998, 139 (01) :8-19